Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

Vaccine - 22 Feb 2002

van Gennip H G P, Bouma A, van Rijn P A, Widjojoatmodjo M N, Moormann R J M

Abstract excerpt

Three mutants with deletions in the E2 gene of the infectious DNA copy of the classical swine fever virus (CSFV) strain-C were constructed: one missing the B/C domain of CSFV-E2 between amino acids (aa) 693 and 746, one missing the A domain between aa 800 and 864, and one missing the complete E2 between aa 689 and 1062. All three CSFV-E2 deletion mutants were unable to generate viable virus, indicating that each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Classical Swine Fever
Share to Classical Swine Fever Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Viral

Share to Genetic Complementation Test

Share to Sequence Deletion

Share to Viral Envelope Proteins

Share to Viral Vaccines

Source

Identifiers

PMID: 11858861
DOI: 10.1016/s0264-410x(01)00497-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.PMID 11858861Read ↗

Classical Swine Fever Virus E <sup>rns</sup> Deletion Mutants: <i>trans</i> -Complementation and Potential Use as Nontransmissible, Modified, Live-Attenuated Marker VaccinesSemantic proximity Read ↗

An attenuated African swine fever virus expressing the E2 glycoprotein of classical swine fever virus protects pigs against challenge of both virusesSemantic proximity Read ↗

Classical swine fever virus replicon particles lacking the E<sup>rns</sup>gene: a potential marker vaccine for intradermal applicationSemantic proximity Read ↗

Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.Semantic proximity Read ↗

Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.Semantic proximity Read ↗

Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: A reviewSemantic proximity Read ↗

Vaccination against classical swine fever virus: limitations and new strategiesSemantic proximity Read ↗

Selection of Classical Swine Fever Virus with Enhanced Pathogenicity Reveals Synergistic Virulence Determinants in E2 and NS4BSemantic proximity Read ↗

Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.Semantic proximity Read ↗

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.Semantic proximity Read ↗

Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFVSemantic proximity Read ↗

Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.